Lakartidningen. 2004 Jun 17;101(25):2172-7.

[BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer].

[Article in Swedish]

Source

Onkologiska kliniken, Universitetssjukhuset, SE221 85 Lund, Sweden. Niklas.Loman@onk.lu.se

Abstract

Increased knowledge of breast cancer genetics has improved the possibilities to predict the future risk of a woman to be diagnosed with breast cancer. In certain families, presymptomatic testing of breast cancer susceptibility genes may be offered, leading to an even more accurate individual risk prediction. As a result, advice regarding follow-up and risk reducing measures may be given to the individuals with the highest risks of cancer. Preventive surgery drastically reduces the risk of having breast or ovarian cancer respectively. The value of increased controls in hereditary high risk women is insufficiently investigated. Further studies are warranted to elucidate the efficacy of chemoprevention in women at a very high risk of breast cancer, e.g. mutation carriers of BRCA1 and BRCA2.

PMID:: 15281304; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Breast Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. [Gynecol Oncol. 2005]
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT. Gynecol Oncol. 2005 May; 97(2):457-67.
Review [Clinical and molecular diagnosis of inherited breast-ovarian cancer]. [J Gynecol Obstet Biol Reprod (...]
Review [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A. J Gynecol Obstet Biol Reprod (Paris). 2003 Apr; 32(2):101-19.
Review Breast cancer and ovarian cancer genetics. [J Long Term Eff Med Implants. ...]
Review Breast cancer and ovarian cancer genetics.
Edlich RF, Winters KL, Lin KY. J Long Term Eff Med Implants. 2005; 15(5):533-45.
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. [Breast Cancer Res. 2006]
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC, Durocher F, Smith P, Simard J, Easton DF, INHERIT BRCAs program members. Breast Cancer Res. 2006; 8(1):R3. Epub 2005 Dec 12.
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. [Clin Cancer Res. 2008]
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Díez O, Alonso MC, Lazaro C, Blanco I, et al. Clin Cancer Res. 2008 May 1; 14(9):2861-9.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

[BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of ...
[BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer].
Lakartidningen. 2004 Jun 17 ;101(25):2172-7.

PubMed
Development of test systems for the detection of compounds that prevent the geno...
Development of test systems for the detection of compounds that prevent the genotoxic effects of heterocyclic aromatic amines: preliminary results with constituents of cruciferous vegetables and other dietary constituents.
J Environ Pathol Toxicol Oncol. 1999 ;18(2):109-18.

PubMed
Chromatin remodeling and stem cell theory of relativity.
Chromatin remodeling and stem cell theory of relativity.
J Cell Physiol. 2004 Oct ;201(1):1-16.

PubMed
Eyes wide shut.
Eyes wide shut.
Endoscopy. 2004 Aug ;36(8):723-5.

PubMed
A master of its sulfate.
A master of its sulfate.
Nat Struct Mol Biol. 2004 Aug ;11(8):686-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

[BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer].

Source

Abstract

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information